
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
There is one avenue starting to create some interest for researchers around the potential for an HIV vaccine -- the ongoing studies of elite controllers, those people whose viral load remains below 50 without ever taking antiretrovirals. In 2006, Bruce Walker, MD, of Harvard Medical School initiated the International HIV Controllers Study with the goal of identifying at least 1,000 elite controllers from around the world to uncover what mechanism in their immune system is responsible for complete viral control. A new report on approximately 4,500 HIVers receiving care at U.S. military hospitals has indicated that 0.55% of them were elite controllers. Since there are about 1 million HIV-infected people in the United States, there should be about 5,000 elite controllers. To date, about 500 have agreed to participate in the study, and there are over 400 researchers and physicians in 200 centers around the world who are collaborating with the U.S. group. The researchers started out by looking to see if elite controllers were simply infected with a defective virus, since HIV is a sloppy replicator and makes lots of bad copies. But the vast majority of elite controllers have a virus that replicates perfectly fine. One clue goes back to 1986, when Jay Levy, a researcher at the University of California, San Francisco, noted that HIV-infected CD4 cells don't reproduce HIV in the presence of CD8 cells (also called T-suppressor cells, or cytotoxic lymphocytes) from long-term nonprogressors. Even though this "antiviral" factor defies identification despite years of research, CD8 cells remain a primary research focus. The Pasteur Institute has reported that HIV-specific CD8 cells from elite controllers have a unique activation marker called HLA-DR, which enables effective HIV suppression upon first contact with HIV. This bypasses the usual mechanism of infection control by CD8s that first requires CD4s to be infected, which then triggers the CD8 response. In other words, the CD 8 cells are able to attack HIV even before it finds its natural host: a CD4 cell. Recently in the journal Immunity, the National Institute of Allergy and Infectious Diseases reported that another part of our defense system, the natural killer cells, worked better in elite controllers, destroying 68% of HIV-infected cells per hour versus 8% in people who'd with AIDS. Then in February of this year a team from Barcelona reported that the dendritic cells in those patients who immediately control HIV secrete higher levels of an antimicrobial peptide that has potent anti-HIV activity. This may be important because dendritic cells sit on our mucous membranes and are therefore the very first cells that confront HIV after exposure. As these studies demonstrate, there are many avenues to explore -- even using the Human Genome Project to study the DNA of elite controllers. If you are an elite controller or want more answers, visit us online at HIVPLUSmag.com. Bowers is an HIV specialist and is board-certified in family medicine. He is in private practice in New York City. Learn more about him on his professional website.
From our Sponsors
Most Popular
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
Plus: Featured Video
Latest Stories
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
SFAF's Dr. Tyler TerMeer says he'll continue to fight for health care for all
January 28 2025 3:00 PM
Lexi Love goes public with HIV status after Trump wipes resources from federal website
January 23 2025 11:23 AM
Plus nominated for 2025 GLAAD Media Award alongside industry giants like Vogue, People, and Variety
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
Meet our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM